Skip to main content
Premium Trial:

Request an Annual Quote

454 Q4 Revenues Topped Most-Read GenomeWeb News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Feb. 2.
1. CuraGen Shows That 454's Q4 Revenue Dipped 1.1 Percent, Not 16 Percent (from Feb. 1)
2. Illumina's Q4 Revenues Leap 163 Percent as Profits Soar (from Feb. 2)
3. Illumina Shares Slump 11 Percent After Firm Said '07 R&D Costs May Double Last Year's (from Feb. 2)
4. EU Sets Aside $650K to Hold Five Genomics Conferences in Europe (from Feb. 1)
5. Stratagene Says QPCR, Reagent Sales Will Drive 7-Percent Growth in Q4 Revenue (from Feb. 1)
The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.